Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
2.
Rev Rhum Engl Ed ; 62(9): 606, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8574637
4.
Rev Neurol (Paris) ; 150(2): 166-8, 1994.
Article in French | MEDLINE | ID: mdl-7863160

ABSTRACT

A generalized epileptic seizure revealed a subactute encephalopathy which was attributed to Hashimoto's thyroiditis. Primary biliary cirrhosis was also discovered. The encephalopathy rapidly followed a favourable course under corticosteroid therapy, which confirms that it was an immune disease.


Subject(s)
Encephalomyelitis/etiology , Thyroiditis, Autoimmune/complications , Adult , Autoantibodies/analysis , Encephalomyelitis/drug therapy , Encephalomyelitis/immunology , Female , Humans , Liver Cirrhosis, Biliary/etiology , Methylprednisolone/therapeutic use , Thyroiditis, Autoimmune/immunology
5.
Rev Rhum Ed Fr ; 60(11): 831-5, 1993 Nov 30.
Article in French | MEDLINE | ID: mdl-8054932

ABSTRACT

A patient with systemic lupus erythematosus developed unexplained fever, nonregenerative anemia, leukopenia, and elevations in serum triglyceride and ferritin levels. Bone marrow studies established the diagnosis of macrophage activation syndrome with active hemophagocytosis. No infectious cause was found but pulmonary nocardiosis developed during the course of the disease. Intravenous gammaglobulin therapy was followed by a transient remission. Cyclophosphamide was given subsequently. In lupus patients, macrophage activation syndrome is exceedingly rare and has the same clinical, laboratory, and histologic features as those seen in patients with hemopathies, infections, or immune deficiencies. Investigations for an underlying infection are often negative, suggesting that the macrophage activation syndrome is due to lupus-related immune changes. Treatment is not standardized and relapses are common. This diagnosis should be considered in lupus patients with febrile pancytopenia.


Subject(s)
Lupus Erythematosus, Systemic/complications , Macrophage Activation , Adult , Blood Cell Count , Bone Marrow/pathology , Female , Fever/etiology , Humans , Immunoglobulins, Intravenous/therapeutic use , Lupus Erythematosus, Systemic/physiopathology , Lupus Erythematosus, Systemic/therapy , Lymphopenia/etiology , Phagocytosis , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...